AS

Alexis S. Statham

3M: 28 patents #1 of 989Top 1%
📍 Woodbury, MN: #1 of 227 inventorsTop 1%
🗺 Minnesota: #7 of 5,843 inventorsTop 1%
Overall (2011): #278 of 364,097Top 1%
28
Patents 2011

Issued Patents 2011

Showing 1–25 of 28 patents

Patent #TitleCo-InventorsDate
8080560 Immune response modifier formulations containing oleic acid and methods Robert J. Nelson 2011-12-20
7939555 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation Robert J. Nelson 2011-05-10
7928118 Reduction of imiquimod impurities in pharmaceutical creams Robert J. Nelson 2011-04-19
7928117 Method of inducing cytokine biosynthesis Robert J. Nelson 2011-04-19
7928116 Method of treating actinic keratosis Robert J. Nelson 2011-04-19
7923463 Methods for stabilizing imiquimod for two months, four months, and six months Robert J. Nelson 2011-04-12
7919501 Method of controlling formation of imiquimod impurities Robert J. Nelson 2011-04-05
7915278 Method of treating basal cell carcinoma Robert J. Nelson 2011-03-29
7915279 Method of treating mollescum contagiosum Robert J. Nelson 2011-03-29
7915277 Method of treating genital or peri-anal warts Robert J. Nelson 2011-03-29
7906525 Reduction of imiquimod impurities at four months using refined oleic acid Robert J. Nelson 2011-03-15
7906524 Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator) Robert J. Nelson 2011-03-15
7906526 Method of treating a dermal and/or mucosal associated condition Robert J. Nelson 2011-03-15
7906527 Reduction of imiquimod impurities using refined oleic acid Robert J. Nelson 2011-03-15
7906543 Method of reducing imiquimod impurity formation Robert J. Nelson 2011-03-15
7902212 Reduction of imiquimod impurities at six months using refined oleic acid Robert J. Nelson 2011-03-08
7902211 Method of inducing interferon biosynthesis Robert J. Nelson 2011-03-08
7902210 Reduction of IMIQUIMOD impurities at two months using refined oleic acid Robert J. Nelson 2011-03-08
7902244 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage) Robert J. Nelson 2011-03-08
7902243 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial Robert J. Nelson 2011-03-08
7902242 Method of stabilizing imiquimod Robert J. Nelson 2011-03-08
7902216 Pharmaceutical creams with refined oleic acid Robert J. Nelson 2011-03-08
7902215 Pharmaceutical creams with reduced imiquimod impurities Robert J. Nelson 2011-03-08
7902214 Method of treating a mucosal and/or dermal associated condition Robert J. Nelson 2011-03-08
7902245 Methods for reducing imiquimod impurities for two months, four months, and six months Robert J. Nelson 2011-03-08